A molecular signature predictive of indolent prostate cancer (Science Translational Medicine, 2013)

(untitled) - Irshad, S; Bansal, M; Castillo-Martin, M; Zheng, T; Aytes, A; Wenske, S; Le Magnen, C; Guarnieri, P; Sumazin, P; Benson, M; Shen, M; Califano, A; et al.